Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus (NCT01600365) | Clinical Trial Compass
UnknownPhase 3
Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
22 participantsStarted 2012-05
Plain-language summary
The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with eye disease with a clinical diagnosis of adenovirus conjunctivitis.
* Patients of both gender aged over 18 years.
* Patients who are not pregnant or nursing.
* Patients able (legally and mentally) to understand and sign informed consent had been signed.
Exclusion Criteria:
* Patients who are in the presence of corticosteroids, either by topical ocular, periocular, intraocular or systemic, for less than 30 days of enrollment and who can not make a drug suspension.
* Patients with serious systemic diseases like AIDS, cancer, etc., which in the opinion of the investigator, may put the patient at risk.
* Patient with a single eye or vision in one eye.